v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Total revenue $ 369 $ 687
Costs of revenue 246 223
Gross profit 123 464
Operating expenses:    
Research and development 1,116 2,019
General and administrative 1,160 1,123
Sales and marketing 179 246
Grant and contract expenses 51 273
Total operating expenses 2,506 3,661
Loss from operations (2,383) (3,197)
Other income (expenses):    
Interest expense (13) (2)
Interest income 41 19
Change in fair value of derivative liabilities 87 2,838
Offering costs of derivative liabilities (550)
Gain (loss) on disposal of assets (25)
Other income, net 1 6
Total other income, net 91 2,311
Net loss before income taxes (2,292) (886)
Provision for income taxes
Net loss $ (2,292) $ (886)
Net loss per share – basic and diluted    
Basic – net loss $ (1.29) $ (10.26)
Diluted – net loss $ (1.29) $ (21.66)
Weighted average common shares outstanding:    
Basic 1,772,732 86,314
Diluted 1,774,343 172,304
Product [Member]    
Total revenue $ 291 $ 309
Grant and Contract [Member]    
Total revenue $ 78 $ 378